U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07549971) titled 'Trial of Labor After One Cesarean Section a Cross-sectional Study After Protocol Introduct... Read More
Singapore, April 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability... Read More
Singapore, April 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzuma... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07551245) titled 'Knee Osteoarthritis Rehab: High-Intensity Laser vs Classical Modalities' on April 19. Bri... Read More
Singapore, April 25 -- The Health Sciences Authority received information related to the study titled 'A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety ... Read More
Singapore, April 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Effi... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07550582) titled 'Mesenteric Vascular Preconditioning Combined With Laparoscopic and Endoscopic Cooperative ... Read More
Singapore, April 25 -- The Health Sciences Authority received information related to the study titled 'Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascen... Read More
Singapore, April 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant... Read More
Singapore, April 25 -- The Health Sciences Authority received information related to the study titled 'A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airwa... Read More